RNA Therapeutics
Part of Healthcare - Genomics & Precision Medicine
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 ALNY | Alnylam Pharmaceuticals, Inc. | $40.3b | $286.92 | -2.2% | 1.1M |
 IONS | Ionis Pharmaceuticals, Inc. Common Stock | $11.9b | $74.25 | -1.9% | 2.1M |
 ARWR | Arrowhead Research Corporation | $9.8b | $76.67 | -3.8% | 1.7M |
 WVE | Wave Life Sciences Ltd. Ordinary Shares | $1.4b | $6.77 | -1.9% | 4.2M |
 CAMP | CAMP4 Therapeutics Corporation Common Stock | $221.7m | $4.31 | -1.6% | 34.8K |
 RNAC | Cartesian Therapeutics, Inc. Common Stock | $199.3m | $7.38 | -10.7% | 120.3K |
 RNA | Atrium Therapeutics, Inc. Common Stock | $194.7m | $13.22 | -0.3% | 234.4K |
 PRQR | ProQR Therapeutics N.V. Ordinary Shares | $155.9m | $1.59 | -3.6% | 413.8K |
 XCUR | Exicure, Inc. Common Stock | $22.1m | $2.94 | -7.5% | 33.1K |
 PHIO | Phio Pharmaceuticals Corp. Common Stock | $13.9m | $1.07 | -4.0% | 228.7K |